Immunity Transplantation
Royal Free London NHS Foundation Trust logo
Royal Free Charity logo
UCL Partners logo

Institute of Immunity and Transplantation

A partnership to bring together world-leading research and clinical trials in a multi-million pound purpose-designed centre at the Royal Free Hospital in Hampstead. The Institute’s vision is to become the leading European hub for experimental medicine in its field, transferring novel research concepts in immunity and transplantation into new diagnostic tools and treatments.

Experimental platforms in:

  • Transplantation and tissue engineering
  • Vaccination
  • Cell therapy
  • Gene therapy

Novel treatments for patients with:

  • Cancer
  • Chronic infection
  • Autoimmunity
  • Inherited diseases

Seminar on T-cell receptor-mediated decision making

Dr John James will be speaking on Exploring the mechanism of T-cell receptor-mediated decision making: how does a receptor count to ten? as part of the Institute's seminar series, on 24 April. More...

PI3K enzymes in immmune activation: forthcoming seminar, 10 April

Dr Klaus Okkenhaug has a long-standing interest in the roles of phosphoinositide 3-kinase (PI3K) enzyme isoforms in immune activation, particularly in T and B cells. His research group is based at the Laboratory of Lymphocyte Signalling and Development at the Babraham Institute and he currently holds a Wellcome Trust New Investigator Award. More...

Dendritic cells: forthcoming seminar

Professor Andrew Macdonald has focused his research career in the States and in Edinburgh on understanding role of Dendritic cells (DC) in driving Th2 responses, in particular following parasite infection. 

Page last modified on 06 feb 14 13:52